scholarly journals Postoperative thoracic hemorrhage after right upper lobectomy with thoracic wall resection during rivaroxaban anticoagulant therapy for deep leg vein thrombosis: A case report

2017 ◽  
Vol 41 ◽  
pp. 340-342 ◽  
Author(s):  
Taiji Kuwata ◽  
Masatoshi Kanayama ◽  
Ayako Hirai ◽  
Shuichi Shinohara ◽  
Masaru Takenaka ◽  
...  
Keyword(s):  
Case Report ◽  
Anticoagulant Therapy ◽  
Thoracic Wall ◽  
Vein Thrombosis ◽  
Thoracic Wall Resection

scholarly journals Disappearance of a major thrombus in the brachiocephalic vein without anticoagulant therapy in a patient with seminoma - a case report

2013 ◽  
Vol 7 (3-4) ◽  
pp. e241-3
Author(s):  
Hiroshi Hongo ◽  
Hiroki Ide ◽  
Katsura Hoshino ◽  
Yota Yasumizu ◽  
Yasumitsu Uchida ◽  
...  
Keyword(s):  
Case Report ◽  
Testicular Cancer ◽  
Anticoagulant Therapy ◽  
Metastatic Tumor ◽  
Brachiocephalic Vein ◽  
Testicular Seminoma ◽  
Vein Thrombosis ◽  
First Case ◽  
Multiple Metastases ◽  
The Right

This is the first case report describing brachiocephalic vein thrombosis without compression by a metastatic tumor during chemotherapy for testicular cancer. According to previous reports of testicular cancer patients with a major thrombus, anticoagulant therapy was required to resolve all cases. However, in the present case, a major thrombus in the brachiocephalic vein disappeared without anticoagulant therapy. This 42-year-old man was diagnosed with testicular seminoma and multiple metastases to the para-aortic lymph nodes. After three cycles of cisplatin, etoposide, and bleomycin (PEB) therapy, a major thrombus in the right brachiocephalic vein was recognized on a CT scan. Although no anticoagulant therapy was undertaken, the thrombus in the right brachiocephalic vein was no longer visible on CT after the 4th cycle of PEB therapy.

scholarly journals When Can a Pulmonary Embolism and Deep Vein Thrombosis Patient Fly Safely Again on Airplane? A Case Report

2021 ◽  
Vol 7 (2) ◽  
Author(s):  
Lin S L ◽  
◽  
Lin W C ◽  
Hsu N W ◽  
◽  
...  
Keyword(s):  
Pulmonary Embolism ◽  
Deep Vein Thrombosis ◽  
Case Report ◽  
Anticoagulant Therapy ◽  
Long Distance ◽  
Vein Thrombosis ◽  
Deep Vein ◽  
Current Guidelines ◽  
Acute Pe

There was no recommendation in the current guidelines for how long after the pulmonary embolism (PE) attack the patient can fly again safely on an airplane. A 45 years old female was admitted to our hospital because of deep vein thrombosis and acute PE. Due to persistent leg swelling and afraid of recurrent PE for long distance flights, this patient received four weeks anticoagulant therapy before flying. Eventually, she flew back safely. This report describes our preliminary experience for managing this patient with deep vein thrombosis and PE.

Acute limb ischemia in a patient with pre-fibrotic myelofibrosis complicated by heparin-induced thrombocytopenia and thrombosis – case report and systematic review of dabigatran use

VASA ◽  
2020 ◽  
pp. 1-6 ◽  
Author(s):  
Marina Di Pilla ◽  
Stefano Barco ◽  
Clara Sacco ◽  
Giovanni Barosi ◽  
Corrado Lodigiani
Keyword(s):  
Systematic Review ◽  
Case Report ◽  
Lower Limb ◽  
Limb Ischemia ◽  
Acute Limb Ischemia ◽  
Review Of The Literature ◽  
Heparin Induced Thrombocytopenia ◽  
Lower Limb Ischemia ◽  
Vein Thrombosis ◽  
Left Lower Limb

Summary: A 49-year-old man was diagnosed with pre-fibrotic myelofibrosis after acute left lower-limb ischemia requiring amputation and portal vein thrombosis. After surgery he developed heparin-induced thrombocytopenia (HIT) with venous thromboembolism, successfully treated with argatroban followed by dabigatran. Our systematic review of the literature supports the use of dabigatran for suspected HIT.

Controlled Trial of the Sequential Use of Streptokinase and Ancrod in the Treatment of Deep Vein Thrombosis of Lower Limb

1977 ◽  
Vol 37 (02) ◽  
pp. 222-232 ◽  
Author(s):  
D. A Tibbutt ◽  
C. N Chesterman ◽  
E. W Williams ◽  
T Faulkner ◽  
A. A Sharp
Keyword(s):  
Deep Vein Thrombosis ◽  
Clinical Improvement ◽  
Anticoagulant Therapy ◽  
Lower Limb ◽  
Oral Anticoagulant ◽  
Controlled Trial ◽  
Oral Anticoagulant Therapy ◽  
Control Group ◽  
Vein Thrombosis ◽  
Deep Vein

SummaryTreatment with streptokinase (‘Kabikinase’) was given to 26 patients with venographically confirmed deep vein thrombosis extending into the popliteal vein or above. Treatment was continued for 4 days and the patients were allocated randomly to oral anticoagulant therapy or a course of treatment with ancrod (‘Arvin’) for 6 days followed by oral anticoagulant therapy. The degree of thrombolysis as judged by further venographic examination at 10 days was not significantly different between the 2 groups. The majority of patients showed clinical improvement but there was no appreciable difference between the groups at 3 and 6 months. Haemorrhagic complications were a more serious problem during the period of treatment with ancrod than during the equivalent period in the control group.

Case report of umbilical vein thrombosis

2019 ◽  
Author(s):  
V.M. Bolotskih, E.R. Semenova
Keyword(s):  
Case Report ◽  
Ultrasound Examination ◽  
Umbilical Vein ◽  
Term Pregnancy ◽  
Vein Thrombosis ◽  
Gestation Age ◽  
Post Term Pregnancy

A case of umbilical vein thrombosis is presented. Thrombotic masses were detected inside umbilical vein during ultrasound examination on the gestation age 40 weeks and 4 days. Such serious complication probably caused by decompensation of chronic placenta insufficiency in post-term pregnancy. In result reduce blood speed and forming thrombus inside umbilical vein

A Rare Case Report of Dabigatran Induced Oral Ulcers

2020 ◽  
Vol 15 (2) ◽  
pp. 160-162
Author(s):  
Ajeet Singh ◽  
Neel Prabha ◽  
Hitesh Yadav
Keyword(s):  
Case Report ◽  
Rare Case ◽  
Warfarin Therapy ◽  
Systemic Embolism ◽  
Vein Thrombosis ◽  
Oral Ulcers ◽  
Retrosternal Pain ◽  
Novel Oral Anticoagulant ◽  
Rare Case Report ◽  
Deep Vein

Background: Dabigatran is a novel oral anticoagulant molecule which is a direct thrombin (Factor IIa) inhibitor and is used for prevention of stroke and systemic embolism. It is easy to administer as compared to warfarin therapy as it does not require routine laboratory monitoring and has fewer drug interactions. Objective: To present a rare case of oral ulcers secondary to dabigatran in a patient with deep vein thrombosis. Case report: A 68-year-old female presented with painful oral ulcers, retrosternal pain and difficulty in swallowing. She had been taking capsule Dabigatran for the prevention of systemic embolism for 2 months. She had experienced symptoms of onset taking dabigatran for 7 days. Clinical examination revealed three tender, well-defined, clean looking ulcers of various sizes present over the dorsum of the tongue. Dabigatran was withdrawn and the patient was on oral proton pump inhibitors. Patient showed remarkable improvement in oral ulcers after 2 weeks. Conclusion: Patient education and counseling should be done regarding this side effect of dabigatran and proper intake of this medicine.

Chronic renal vein thrombosis in a renal allograft. Case Report

Nephrology ◽  
2003 ◽  
Vol 8 (5) ◽  
pp. 248-250 ◽  
Author(s):  
WAI H LIM ◽  
GREG VAN SCHIE ◽  
KEVIN WARR
Keyword(s):  
Case Report ◽  
Renal Vein ◽  
Renal Allograft ◽  
Renal Vein Thrombosis ◽  
Vein Thrombosis
Sign in / Sign up

Export Citation Format

Share Document